Global Opportunities in the Endovascular Treatment of Chronic Limb Ischemia and Venous Thromboembolism

105 Pages | 55 Exhibits | Forecasts Through 2023

Order individually or subscribe to Medtech Pro and get a complete intel platform.

Buy This Report Subscribe To All Reports
market-report-samples/GlobalMarketSegments2.jpg
market-report-samples/GlobalMarketSegments3caps.jpg
market-report-samples/GlobalMarketSegmentsCaps.jpg

Overview

This report represents a detailed analysis of the current and forecast markets for endovascular treatment of chronic limb ischemia and venous thromboembolism.  The report includes a thorough analysis which details:

  • Current Market Size & Forecasts
  • Competitive Landscape & Supplier Shares
  • Current & Emerging Technology Trends
  • Procedure Volumes
  • Average Selling Prices
  • Market Trends & Outlook
  • More


Product Segments Covered Include:

  • Additional Segments Covered
  • Customization Available to Subscribers

 

This report is available individually or in a Medtech Pro subscription. 

Companies We Work With

  • 0-Minnetronix.jpg
  • 1-jnj.png
  • 2-medtronic.png
  • 3-abbott.png
  • 4-baxter.png
  • 7-bostonscientific.png
  • 8-bd.png
  • 9-smithnephew.png
  • 10-stryker.png
  • 33m.png
  • allergan.jpg
  • bain.jpg
  • bbraun.png
  • beckmancoulter.png
  • cardinal.png
  • depuysynthes.png
  • drager.png
  • edwardslifesciences.png
  • ethicon.png
  • ge.png
  • gore.png
  • hospira.png
  • jlabs.jpg
  • kimberlyclark.png
  • merck.jpg
  • olympus.png
  • orthofix.png
  • philips.png
  • sanofigenzyme.png
  • teleflex.jpg
  • terumo.png
  • zimmerbiomet.png